EGFR Activation Increases Parathyroid Hyperplasia and Calcitriol Resistance in Kidney Disease

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2007040406
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Vitamin D Receptor Activation With Calcitriol for Reducing Urinary Angiotensinogen in Patients With Type 2 Diabetic Chronic Kidney Disease

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2015English

Is Calcitriol Life-Protective for Patients With Chronic Kidney Disease?

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Magnesium Modifies the Impact of Calcitriol Treatment on Vascular Calcification in Experimental Chronic Kidney Disease

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2015English

Analysis of Related Factors Affecting Serum Parathyroid Hormone in Chronic Kidney Disease

Advances in Clinical Medicine
2016English

Cilostazol Attenuates Intimal Hyperplasia in a Mouse Model of Chronic Kidney Disease

PLoS ONE
Multidisciplinary
2017English

Effect of Insulin Resistance in Chronic Kidney Disease

Endocrinology & Metabolic Syndrome
2016English

KRAS, HRAS and EGFR Mutations in Sporadic Sebaceous Gland Hyperplasia

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Paradigm Shift in the Surgical Management of Multigland Parathyroid Hyperplasia

JAMA Surgery
Surgery
2014English

Economic Evaluation of Egfr Control in Patients With Chronic Kidney Disease in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy